NHS England will be the first health service in the world to routinely offer genomic medicine from 1 October 2018, enabling the analysis of patient DNA to help diagnose rare diseases, match patients to the most effective treatments, and reduce adverse drug reactions.
The move comes as the NHS celebrates its 70th birthday and represents an important step towards ‘precision medicine’ in the healthcare service, enabling more efficient therapies tailored to individual patients.
